Diltiazem Hydrochloride SR (WW) Pellets
Rraynex supplies Diltiazem Hydrochloride SR (WW) Pellets as sustained-release pellets in the Calcium Channel Blocker category, in a strength of 45%.
Product overview
Diltiazem is a calcium channel blocker used for hypertension, angina and heart-rate control, commonly as sustained-release capsules.
Pharmaceutical pellets are small, free-flowing spherical units filled into capsules or compressed into MUPS tablets. Dividing a dose across many pellets gives more reproducible gastric transit and release than a single-unit tablet.
Formulation and release profile
Sustained-release (SR) pellets release the drug gradually through a release-controlling coat or matrix, flattening plasma peaks and reducing dosing frequency.
Pharmaceutical applications
- Capsule filling of diltiazem hydrochloride sr (ww) pellets for cardiovascular products.
- Multiparticulate dosage forms where reproducible release matters.
- Formulation development, scale-up and commercial supply programmes.
Product specifications
- Product
- Diltiazem Hydrochloride SR (WW) Pellets
- Form
- sustained-release Pellets
- Therapeutic category
- Calcium Channel Blocker
- Strength
- 45%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Diltiazem Hydrochloride SR (WW) Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Diltiazem products from Rraynex
- Diltiazem FR / SR — Pellets